Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension

Journal of Gastrointestinal Surgery

Volumn 8, Issue 1, 2004, Pages 120-126

  Kercher, Kent W ^a   Carbonell, Alfredo M ^a   Heniford, B Todd ^a   Matthews, Brent D ^a   Cunningham, Dawn M ^a   Reindollar, Robert W ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Hepatitis; Interferon; Laparoscopic splenectomy; Portal hypertension; Thrombocytopenia

Indexed keywords

PEGINTERFERON; RIBAVIRIN;

ADULT; ARTICLE; ATELECTASIS; BLEEDING; BODY MASS; CELLULITIS; CLINICAL ARTICLE; DEMOGRAPHY; ERYTHROCYTE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEPATITIS C; HUMAN; LAPAROSCOPIC SURGERY; LENGTH OF STAY; LIVER CIRRHOSIS; MALE; MODEL; OPERATION DURATION; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; SPLEEN WEIGHT; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TROCAR;

EID: 1642546196     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2003.10.009     Document Type: Article

References (27)

1. Anonymous. Hepatitis C - global prevalence (update). World Health Organization Weekly Epidemiological Record. 74:1999;425-427.
2. Poynard T., Marcellin P., Lee S.S., Niederau C., Minuk G.S., Ideo G., Bain V., Heathcote J., Zeuzem S., Trepo C., Albrecht J. Randomised trial of IFN alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet. 352:1998;1426-1432.
3. McHutchison J.G., Gordon S.C., Schiff E.R., Shiffman M.L., Lee W.M., Rustgi V.K., Goodman Z.D., Ling M.H., Cort S., Albrecht J.K. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 339:1998;1485-1492.
4. Youngster S., Wang Y.S., Grace M., Bausch J., Bordens R., Wyss D.F. Structure, biology, and therapeutic implications of pegylated interferon alpha-2b. Curr Pharm Des. 8:2002;2139-2157.
5. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Koury K., Ling M., Albrecht J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet. 358:2001;958-965.
6. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales F.L. Jr., Haussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 347:2002;975-982.
7. McHutchison J.G., Manns M., Patel K., Poynard T., Lindsay K.L., Trepo C., Dienstag J., Lee W.M., Mak C., Garaud J.J., Albrecht J.K. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology. 123:2002;1061-1069.
8. Kercher K.W., Matthews B.D., Walsh R.M., Sing R.F., Backus C.L., Heniford B.T. Laparoscopic splenectomy for massive splenomegaly. Am J Surg. 183:2002;192-196.
9. Schmidt K.G., Rasmussen J.W., Rasmussen A.D. Kinetics of 111In-labelled platelets in healthy subjects. Scand J Haematol. 34:1985;370-377.
10. Schmidt K.G., Rasmussen J.W., Bekker C., Madsen P.E. Kinetics and in vivo distribution of 111-In-labelled autologous platelets in chronic hepatic disease: Mechanisms of thrombocytopenia. Scand J Haematol. 34:1985;39-46.
11. Renault P.F., Hoofnagle J.H. Side effects of alpha interferon. Semin Liver Dis. 9:(4):1989;273-277.
12. Martin T.G., Shuman M.A. Interferon-induced thrombocytopenia: Is it time for thrombopoietin. Hepatology. 28:1998;1430-1432.
13. Hoofnagle J.H. Thrombocytopenia during interferon alfa therapy. JAMA. 266:1991;849.
14. Peck-Radosavljevic M., Wichlas M., Pidlich J., Sims P., Meng G., Zacherl J., Garg S., Datz C., Gangl A., Ferenci P. Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology. 28:1998;1424-1429.
15. Gaydos L.A., Freireich E.J., Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. JAMA. 266:1962;905-909.
16. Mutchnick M.G., Lerner E., Conn H.O. Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci. 25:1980;929-938.
17. Jabbour N., Zajko A., Orons P., Irish W., Fung J.J., Selby R.R. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci. 43:1998;2459-2462.
18. el-Khishen M.A., Henderson J.M., Millikan W.J. Jr., Kutner M.H., Warren W.D. Splenectomy is contraindicated for thrombocytopenia secondary to portal hypertension. Surg Gynecol Obstet. 160:1985;233-238.
19. Soper N.J., Rikkers L.F. Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg. 144:(6):1982;700-703.
20. Tomikawa M., Hashizume M., Akahoshi T., Shimabukuro R., Gotoh N., Ohta M., Sugimachi K. Effects of splenectomy on liver volume and prognosis of cirrhosis in patients with esophageal varices. J Gastroenterol Hepatol. 17:2002;77-80.
21. Hashizume M., Tomikawa M., Akahoshi T., Tanoue K., Gotoh N., Konishi K., Okita K., Tsutsumi N., Shimabukuro R., Yamaguchi S., Sugimachi K. Laparoscopic splenectomy for portal hypertension. Hepatogastroenterology. 49:2002;847-852.
22. Schwartz J., Leber M.D., Gillis S., Giunta A., Eldor A., Bussel J.B. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol. 72:2003;94-98.
23. Heniford B.T., Matthews B.D., Answini G.A., Walsh R.M. Laparoscopic splenectomy for malignant diseases. Semin Laparosc Surg. 7:2000;93-100.
24. Pollinger HS, Poplin M, Matthews BD, Kercher KW, Sing RF, Heniford BT. Etiology, clinical features, microbiology, and surgical management of splenic abscesses. Presented at the Southeastern Surgical Congress, Nashville, TN, 2002.
25. Winslow E.R., Brunt L.M., Drebin J.A., Soper N.J., Klingensmith M.E. Portal vein thrombosis after splenectomy. Am J Surg. 184:2002;631-635. discussion 635-636.
26. Hassn A.M., Al-Fallouji M.A., Ouf T.I., Saad R. Portal vein thrombosis following splenectomy. Br J Surg. 87:2000;362-373.
27. Chaffanjon P.C., Brichon P.Y., Ranchoup Y., Gressin R., Sotto J.J. Portal vein thrombosis following splenectomy for hematologic disease: Prospective study with Doppler color flow imaging. World J Surg. 22:1998;1082-1086.